Natco Pharma Approves ₹1,279.36 Crore Rights Issue
Natco Pharma Ltd · Outcome · 25 Sept 2026, 4:48 pm
Natco Pharma Approves ₹1,279.36 Crore Rights Issue Natco Pharma's board approved a rights issue of up to 1,70,58,082 equity shares (face value ₹2) at ₹750 per share (₹748 premium), raising up to ₹12,79.36 crore. The entitlement ratio is set at 2:21 (2 rights shares for every 21 shares held) with a record date of 1st Oct'26. The issue opens on 12th Oct'26 and closes on 22nd Oct'26, with on-market renunciation from 12th Oct'26 to 16th Oct'26. Outstanding equity will expand from 17,91,09,870 to 19,61,67,952 shares post-issue upon full subscription.
Original exchange filing (PDF)
More announcements from Natco Pharma Ltd
- Intimation of Investor Meet · 17 Nov 2026
- Audio link of Earnings Conference Call Q2FY27 · 14 Nov 2026
- Q2 FY27 Earnings Presentation · 13 Nov 2026
- Un audited Financial Results for the quarter and half year ended 30th September, 2026 · 13 Nov 2026
- 19th November, 2026 is the Record Date for the payment of 2nd Interim Dividend for FY 2026-27 · 13 Nov 2026
- Natco Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026 and declaration of 2nd Interim Dividend for FY 2026-27 · 13 Nov 2026
- Outcome of Board Meeting · 13 Nov 2026
- Intimation of schedule of Concall · 13 Nov 2026
